FIELD: medicine; pulmonology and pharmacology. SUBSTANCE: essence of the inandvention lies in using levadopa in the capacity of broncholythic agent. EFFECT: higher efficiency of treating chronic obstructive bronchitis due to intensified broncholythic effect.
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATING AGENT | 1986 |
|
RU2024257C1 |
| METHOD FOR DETERMINING DISTURBED IMMUNITY IN PATIENTS WITH CHRONIC BRONCHITIS | 1988 |
|
RU2050002C1 |
| METHOD OF DIAGNOSTICS OF PREASTHMA OF PATIENTS HAVING DUST OBSTRUCTIVE BRONCHITIS | 0 |
|
SU1169618A1 |
| METHOD OF DIAGNOSIS OF EMPHYZEMA | 0 |
|
SU1475600A1 |
| DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS METHOD USABLE IN BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE CASES | 2004 |
|
RU2267987C1 |
| METHOD OF TREATMENT OF PATIENTS WITH BRONCHOOBSTRUCTIVE SYNDROME | 1996 |
|
RU2136273C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2488830C1 |
| METHOD OF TREATING CHRONIC OBSTRUCTIVE BRONCHITIS | 2015 |
|
RU2600822C1 |
| METHOD OF TREATING CHRONIC BRONCHITIS | 2005 |
|
RU2286795C1 |
| METHOD FOR PROGNOSIS OF PROGRESSIVE CHRONIC INFLAMMATORY PROCESS IN THE LUNGS | 0 |
|
SU1672362A1 |
